Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| Questionnaire sur la maladie de Parkinson-39× | Questionnaire d'Impact de la Fibromyalgie× | |
|---|---|---|
| Domaine | Résultats de santé | Résultats de santé |
| Famille | Process / pipeline | Process / pipeline |
| Année d'origine≠ | 1997 | 1991 |
| Auteur d'origine≠ | Crispin Jenkinson et al. | Cynthia S. Burckhardt et al. |
| Type≠ | Self-report quality of life questionnaire | Self-report symptom and functional impairment questionnaire |
| Source fondatrice≠ | Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357. DOI ↗ | Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗ |
| Alias | PDQ-39, Parkinson's Disease Questionnaire, PDQ | FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire |
| Apparentées | 4 | 4 |
| Résumé≠ | The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders. | The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice. |
| ScholarGateJeu de données ↗ |
|
|